Sio Capital Management, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

  • $189 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$6.1 - $7.15 $193,717 - $227,062
31,757 Added 7.51%
454,355 $491,000
Q3 2021

Nov 15, 2021
BUY
$8.02 - $11.0 $45,914 - $62,975
5,725 Added 1.37%
422,598 $2.23 Million
Q2 2021

Aug 16, 2021
BUY
$7.59 - $10.48 $3.16 Million - $4.37 Million
416,873 New
416,873 $2.47 Million

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.64M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email